Green Biosynthesis of Silver Nanoparticles Using Vallarai Chooranam and Their Potential Biomedical Applications

The synthesis of silver nanoparticles was done using vallarai chooranam as a bio reducing agent and ascertained by UV–Visible spectrum at 432 nm. Fourier transform infra-red spectrum revealed that the proteins and other ligands were liable for the capping of synthesized silver nanoparticles (VC-AgNP...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of inorganic and organometallic polymers and materials 2020-11, Vol.30 (11), p.4709-4719
Hauptverfasser: Sathiyaraj, Sivaji, Suriyakala, Gunasekaran, Gandhi, Arumugam Dhanesh, Saranya, Sivakumar, Santhoshkumar, Murali, Kavitha, Purushothaman, Babujanarthanam, Ranganathan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4719
container_issue 11
container_start_page 4709
container_title Journal of inorganic and organometallic polymers and materials
container_volume 30
creator Sathiyaraj, Sivaji
Suriyakala, Gunasekaran
Gandhi, Arumugam Dhanesh
Saranya, Sivakumar
Santhoshkumar, Murali
Kavitha, Purushothaman
Babujanarthanam, Ranganathan
description The synthesis of silver nanoparticles was done using vallarai chooranam as a bio reducing agent and ascertained by UV–Visible spectrum at 432 nm. Fourier transform infra-red spectrum revealed that the proteins and other ligands were liable for the capping of synthesized silver nanoparticles (VC-AgNPs). Crystalline nature, spherical shapes particles with the size between 40 to 50 nm and elemental composition were found using X-ray Diffraction, Transmission Electron Microscopy and Energy-dispersive X-ray spectroscopy. By using Dynamic Light Scattering analysis, the average size of silver nanoparticles was found to be 43.1 nm and the zeta potential value was − 47.5 mV implying the stability of VC-AgNPs. The antibacterial activity of VC-AgNPs showed the maximum and minimum zone of inhibition towards E. coli (23 ± 0.69 mm) and Bacillus subtilis (12.67 ± 0.38 mm). The in vitro antioxidant study revealed the free radical scavenging activity of VC-AgNPs by 2,2-diphenyl-1-picrylhydrazyl and Nitric oxide at the inhibitory concentration (IC 50 ) of 23.11 ± 2.05 µg/mL and 36.52 ± 2.37 µg/mL respectively. The anthelmintic efficacy of VC-AgNPs against Pheretima posthumus mortality was found to be 87% at 5 µg/cm 2 . VC-AgNPs showed significant larvicidal activity against Culex quinquefasciatus with a lethal dose of 0.788 ppm and also VC-AgNPs significantly inhibited the production of acetylcholinesterase with the IC 50 value of 0.875 ppm. VC-AgNPs displayed remarkable cytotoxicity against the lung cancer cell line A549 in a dose dependent way with the IC 50 value of 125 µg/mL. We demonstrated that VC-AgNPs can be further exploited as a potential candidate for antibacterial, antioxidant, anthelmintic, larvicidal, anti-acetylcholinesterase and anticancer activity. Graphic Abstract
doi_str_mv 10.1007/s10904-020-01683-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2450782166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2450782166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e6aa0db83bc4946b7e3ac85be003b0b28a61f73c61446997236384f245eb052b3</originalsourceid><addsrcrecordid>eNp9kMFOwzAQRC0EEqXwA5wscQ6sY8dOjqWCglQBEi1Xy06d1lVqBzsg9e9xCYIbp53DzOzuQ-iSwDUBEDeRQAUsgxwyILykmThCI1IIlhFWkONfzegpOotxC0BLKMgI-VkwxuFb6-Pe9RsTbcS-wa-2_TQBPynnOxV6W7cm4mW0bo3fVNuqoCyebrwPyqkdVm6FFxtjA37xvXG9Ve2hcWdWtk5y0nVtEr31Lp6jk0a10Vz8zDFa3t8tpg_Z_Hn2OJ3Ms5oWvM8MVwpWuqS6ZhXjWhiq6rLQJh2uQeel4qQRtObpJV5VIqeclqzJWWE0FLmmY3Q19HbBv3-Y2Mut_wgurZTJBKLMCefJlQ-uOvgYg2lkF-xOhb0kIA9g5QBWJrDyG6wUKUSHUExmtzbhr_qf1Bf_63wY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2450782166</pqid></control><display><type>article</type><title>Green Biosynthesis of Silver Nanoparticles Using Vallarai Chooranam and Their Potential Biomedical Applications</title><source>SpringerLink Journals</source><creator>Sathiyaraj, Sivaji ; Suriyakala, Gunasekaran ; Gandhi, Arumugam Dhanesh ; Saranya, Sivakumar ; Santhoshkumar, Murali ; Kavitha, Purushothaman ; Babujanarthanam, Ranganathan</creator><creatorcontrib>Sathiyaraj, Sivaji ; Suriyakala, Gunasekaran ; Gandhi, Arumugam Dhanesh ; Saranya, Sivakumar ; Santhoshkumar, Murali ; Kavitha, Purushothaman ; Babujanarthanam, Ranganathan</creatorcontrib><description>The synthesis of silver nanoparticles was done using vallarai chooranam as a bio reducing agent and ascertained by UV–Visible spectrum at 432 nm. Fourier transform infra-red spectrum revealed that the proteins and other ligands were liable for the capping of synthesized silver nanoparticles (VC-AgNPs). Crystalline nature, spherical shapes particles with the size between 40 to 50 nm and elemental composition were found using X-ray Diffraction, Transmission Electron Microscopy and Energy-dispersive X-ray spectroscopy. By using Dynamic Light Scattering analysis, the average size of silver nanoparticles was found to be 43.1 nm and the zeta potential value was − 47.5 mV implying the stability of VC-AgNPs. The antibacterial activity of VC-AgNPs showed the maximum and minimum zone of inhibition towards E. coli (23 ± 0.69 mm) and Bacillus subtilis (12.67 ± 0.38 mm). The in vitro antioxidant study revealed the free radical scavenging activity of VC-AgNPs by 2,2-diphenyl-1-picrylhydrazyl and Nitric oxide at the inhibitory concentration (IC 50 ) of 23.11 ± 2.05 µg/mL and 36.52 ± 2.37 µg/mL respectively. The anthelmintic efficacy of VC-AgNPs against Pheretima posthumus mortality was found to be 87% at 5 µg/cm 2 . VC-AgNPs showed significant larvicidal activity against Culex quinquefasciatus with a lethal dose of 0.788 ppm and also VC-AgNPs significantly inhibited the production of acetylcholinesterase with the IC 50 value of 0.875 ppm. VC-AgNPs displayed remarkable cytotoxicity against the lung cancer cell line A549 in a dose dependent way with the IC 50 value of 125 µg/mL. We demonstrated that VC-AgNPs can be further exploited as a potential candidate for antibacterial, antioxidant, anthelmintic, larvicidal, anti-acetylcholinesterase and anticancer activity. Graphic Abstract</description><identifier>ISSN: 1574-1443</identifier><identifier>EISSN: 1574-1451</identifier><identifier>DOI: 10.1007/s10904-020-01683-7</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Anticancer properties ; Antioxidants ; Biocompatibility ; Biomedical materials ; Biosynthesis ; Chemistry ; Chemistry and Materials Science ; E coli ; Fourier transforms ; Free radicals ; Inorganic Chemistry ; Nanoparticles ; Nitric oxide ; Organic Chemistry ; Photon correlation spectroscopy ; Polymer Sciences ; Reducing agents ; Scavenging ; Silver ; Spectrum analysis ; Toxicity ; Visible spectrum ; Zeta potential</subject><ispartof>Journal of inorganic and organometallic polymers and materials, 2020-11, Vol.30 (11), p.4709-4719</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e6aa0db83bc4946b7e3ac85be003b0b28a61f73c61446997236384f245eb052b3</citedby><cites>FETCH-LOGICAL-c356t-e6aa0db83bc4946b7e3ac85be003b0b28a61f73c61446997236384f245eb052b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10904-020-01683-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10904-020-01683-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids></links><search><creatorcontrib>Sathiyaraj, Sivaji</creatorcontrib><creatorcontrib>Suriyakala, Gunasekaran</creatorcontrib><creatorcontrib>Gandhi, Arumugam Dhanesh</creatorcontrib><creatorcontrib>Saranya, Sivakumar</creatorcontrib><creatorcontrib>Santhoshkumar, Murali</creatorcontrib><creatorcontrib>Kavitha, Purushothaman</creatorcontrib><creatorcontrib>Babujanarthanam, Ranganathan</creatorcontrib><title>Green Biosynthesis of Silver Nanoparticles Using Vallarai Chooranam and Their Potential Biomedical Applications</title><title>Journal of inorganic and organometallic polymers and materials</title><addtitle>J Inorg Organomet Polym</addtitle><description>The synthesis of silver nanoparticles was done using vallarai chooranam as a bio reducing agent and ascertained by UV–Visible spectrum at 432 nm. Fourier transform infra-red spectrum revealed that the proteins and other ligands were liable for the capping of synthesized silver nanoparticles (VC-AgNPs). Crystalline nature, spherical shapes particles with the size between 40 to 50 nm and elemental composition were found using X-ray Diffraction, Transmission Electron Microscopy and Energy-dispersive X-ray spectroscopy. By using Dynamic Light Scattering analysis, the average size of silver nanoparticles was found to be 43.1 nm and the zeta potential value was − 47.5 mV implying the stability of VC-AgNPs. The antibacterial activity of VC-AgNPs showed the maximum and minimum zone of inhibition towards E. coli (23 ± 0.69 mm) and Bacillus subtilis (12.67 ± 0.38 mm). The in vitro antioxidant study revealed the free radical scavenging activity of VC-AgNPs by 2,2-diphenyl-1-picrylhydrazyl and Nitric oxide at the inhibitory concentration (IC 50 ) of 23.11 ± 2.05 µg/mL and 36.52 ± 2.37 µg/mL respectively. The anthelmintic efficacy of VC-AgNPs against Pheretima posthumus mortality was found to be 87% at 5 µg/cm 2 . VC-AgNPs showed significant larvicidal activity against Culex quinquefasciatus with a lethal dose of 0.788 ppm and also VC-AgNPs significantly inhibited the production of acetylcholinesterase with the IC 50 value of 0.875 ppm. VC-AgNPs displayed remarkable cytotoxicity against the lung cancer cell line A549 in a dose dependent way with the IC 50 value of 125 µg/mL. We demonstrated that VC-AgNPs can be further exploited as a potential candidate for antibacterial, antioxidant, anthelmintic, larvicidal, anti-acetylcholinesterase and anticancer activity. Graphic Abstract</description><subject>Anticancer properties</subject><subject>Antioxidants</subject><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Biosynthesis</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>E coli</subject><subject>Fourier transforms</subject><subject>Free radicals</subject><subject>Inorganic Chemistry</subject><subject>Nanoparticles</subject><subject>Nitric oxide</subject><subject>Organic Chemistry</subject><subject>Photon correlation spectroscopy</subject><subject>Polymer Sciences</subject><subject>Reducing agents</subject><subject>Scavenging</subject><subject>Silver</subject><subject>Spectrum analysis</subject><subject>Toxicity</subject><subject>Visible spectrum</subject><subject>Zeta potential</subject><issn>1574-1443</issn><issn>1574-1451</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMFOwzAQRC0EEqXwA5wscQ6sY8dOjqWCglQBEi1Xy06d1lVqBzsg9e9xCYIbp53DzOzuQ-iSwDUBEDeRQAUsgxwyILykmThCI1IIlhFWkONfzegpOotxC0BLKMgI-VkwxuFb6-Pe9RsTbcS-wa-2_TQBPynnOxV6W7cm4mW0bo3fVNuqoCyebrwPyqkdVm6FFxtjA37xvXG9Ve2hcWdWtk5y0nVtEr31Lp6jk0a10Vz8zDFa3t8tpg_Z_Hn2OJ3Ms5oWvM8MVwpWuqS6ZhXjWhiq6rLQJh2uQeel4qQRtObpJV5VIqeclqzJWWE0FLmmY3Q19HbBv3-Y2Mut_wgurZTJBKLMCefJlQ-uOvgYg2lkF-xOhb0kIA9g5QBWJrDyG6wUKUSHUExmtzbhr_qf1Bf_63wY</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Sathiyaraj, Sivaji</creator><creator>Suriyakala, Gunasekaran</creator><creator>Gandhi, Arumugam Dhanesh</creator><creator>Saranya, Sivakumar</creator><creator>Santhoshkumar, Murali</creator><creator>Kavitha, Purushothaman</creator><creator>Babujanarthanam, Ranganathan</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20201101</creationdate><title>Green Biosynthesis of Silver Nanoparticles Using Vallarai Chooranam and Their Potential Biomedical Applications</title><author>Sathiyaraj, Sivaji ; Suriyakala, Gunasekaran ; Gandhi, Arumugam Dhanesh ; Saranya, Sivakumar ; Santhoshkumar, Murali ; Kavitha, Purushothaman ; Babujanarthanam, Ranganathan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e6aa0db83bc4946b7e3ac85be003b0b28a61f73c61446997236384f245eb052b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anticancer properties</topic><topic>Antioxidants</topic><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Biosynthesis</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>E coli</topic><topic>Fourier transforms</topic><topic>Free radicals</topic><topic>Inorganic Chemistry</topic><topic>Nanoparticles</topic><topic>Nitric oxide</topic><topic>Organic Chemistry</topic><topic>Photon correlation spectroscopy</topic><topic>Polymer Sciences</topic><topic>Reducing agents</topic><topic>Scavenging</topic><topic>Silver</topic><topic>Spectrum analysis</topic><topic>Toxicity</topic><topic>Visible spectrum</topic><topic>Zeta potential</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sathiyaraj, Sivaji</creatorcontrib><creatorcontrib>Suriyakala, Gunasekaran</creatorcontrib><creatorcontrib>Gandhi, Arumugam Dhanesh</creatorcontrib><creatorcontrib>Saranya, Sivakumar</creatorcontrib><creatorcontrib>Santhoshkumar, Murali</creatorcontrib><creatorcontrib>Kavitha, Purushothaman</creatorcontrib><creatorcontrib>Babujanarthanam, Ranganathan</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of inorganic and organometallic polymers and materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sathiyaraj, Sivaji</au><au>Suriyakala, Gunasekaran</au><au>Gandhi, Arumugam Dhanesh</au><au>Saranya, Sivakumar</au><au>Santhoshkumar, Murali</au><au>Kavitha, Purushothaman</au><au>Babujanarthanam, Ranganathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Green Biosynthesis of Silver Nanoparticles Using Vallarai Chooranam and Their Potential Biomedical Applications</atitle><jtitle>Journal of inorganic and organometallic polymers and materials</jtitle><stitle>J Inorg Organomet Polym</stitle><date>2020-11-01</date><risdate>2020</risdate><volume>30</volume><issue>11</issue><spage>4709</spage><epage>4719</epage><pages>4709-4719</pages><issn>1574-1443</issn><eissn>1574-1451</eissn><abstract>The synthesis of silver nanoparticles was done using vallarai chooranam as a bio reducing agent and ascertained by UV–Visible spectrum at 432 nm. Fourier transform infra-red spectrum revealed that the proteins and other ligands were liable for the capping of synthesized silver nanoparticles (VC-AgNPs). Crystalline nature, spherical shapes particles with the size between 40 to 50 nm and elemental composition were found using X-ray Diffraction, Transmission Electron Microscopy and Energy-dispersive X-ray spectroscopy. By using Dynamic Light Scattering analysis, the average size of silver nanoparticles was found to be 43.1 nm and the zeta potential value was − 47.5 mV implying the stability of VC-AgNPs. The antibacterial activity of VC-AgNPs showed the maximum and minimum zone of inhibition towards E. coli (23 ± 0.69 mm) and Bacillus subtilis (12.67 ± 0.38 mm). The in vitro antioxidant study revealed the free radical scavenging activity of VC-AgNPs by 2,2-diphenyl-1-picrylhydrazyl and Nitric oxide at the inhibitory concentration (IC 50 ) of 23.11 ± 2.05 µg/mL and 36.52 ± 2.37 µg/mL respectively. The anthelmintic efficacy of VC-AgNPs against Pheretima posthumus mortality was found to be 87% at 5 µg/cm 2 . VC-AgNPs showed significant larvicidal activity against Culex quinquefasciatus with a lethal dose of 0.788 ppm and also VC-AgNPs significantly inhibited the production of acetylcholinesterase with the IC 50 value of 0.875 ppm. VC-AgNPs displayed remarkable cytotoxicity against the lung cancer cell line A549 in a dose dependent way with the IC 50 value of 125 µg/mL. We demonstrated that VC-AgNPs can be further exploited as a potential candidate for antibacterial, antioxidant, anthelmintic, larvicidal, anti-acetylcholinesterase and anticancer activity. Graphic Abstract</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s10904-020-01683-7</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1574-1443
ispartof Journal of inorganic and organometallic polymers and materials, 2020-11, Vol.30 (11), p.4709-4719
issn 1574-1443
1574-1451
language eng
recordid cdi_proquest_journals_2450782166
source SpringerLink Journals
subjects Anticancer properties
Antioxidants
Biocompatibility
Biomedical materials
Biosynthesis
Chemistry
Chemistry and Materials Science
E coli
Fourier transforms
Free radicals
Inorganic Chemistry
Nanoparticles
Nitric oxide
Organic Chemistry
Photon correlation spectroscopy
Polymer Sciences
Reducing agents
Scavenging
Silver
Spectrum analysis
Toxicity
Visible spectrum
Zeta potential
title Green Biosynthesis of Silver Nanoparticles Using Vallarai Chooranam and Their Potential Biomedical Applications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T04%3A17%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Green%20Biosynthesis%20of%20Silver%20Nanoparticles%20Using%20Vallarai%20Chooranam%20and%20Their%20Potential%20Biomedical%20Applications&rft.jtitle=Journal%20of%20inorganic%20and%20organometallic%20polymers%20and%20materials&rft.au=Sathiyaraj,%20Sivaji&rft.date=2020-11-01&rft.volume=30&rft.issue=11&rft.spage=4709&rft.epage=4719&rft.pages=4709-4719&rft.issn=1574-1443&rft.eissn=1574-1451&rft_id=info:doi/10.1007/s10904-020-01683-7&rft_dat=%3Cproquest_cross%3E2450782166%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2450782166&rft_id=info:pmid/&rfr_iscdi=true